FDA Approved: NGENLA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved NGENLA (somatrogon-ghla) from Pfizer as an original biologics license application to treat growth hormone deficiency, including pediatric patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• NGENLA (SOMATROGON-GHLA)

Snippet

ORIG AP for NGENLA (SOMATROGON-GHLA)